

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to peptidoglycan (GO:0032494) | 5.02280702 |
| 2 | DNA deamination (GO:0045006) | 4.89944370 |
| 3 | tricarboxylic acid cycle (GO:0006099) | 4.88074074 |
| 4 | ribosomal small subunit assembly (GO:0000028) | 4.77391437 |
| 5 | oxidative phosphorylation (GO:0006119) | 4.56089115 |
| 6 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.37255101 |
| 7 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.27323091 |
| 8 | lysine metabolic process (GO:0006553) | 4.15119921 |
| 9 | lysine catabolic process (GO:0006554) | 4.15119921 |
| 10 | negative regulation of interleukin-12 production (GO:0032695) | 4.05817440 |
| 11 | viral transcription (GO:0019083) | 4.02643067 |
| 12 | 2-oxoglutarate metabolic process (GO:0006103) | 3.96357335 |
| 13 | low-density lipoprotein particle clearance (GO:0034383) | 3.95390007 |
| 14 | glycosphingolipid catabolic process (GO:0046479) | 3.92937162 |
| 15 | translational termination (GO:0006415) | 3.92804101 |
| 16 | sarcomere organization (GO:0045214) | 3.92310031 |
| 17 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.89927857 |
| 18 | translational elongation (GO:0006414) | 3.76883324 |
| 19 | ATP synthesis coupled proton transport (GO:0015986) | 3.67403182 |
| 20 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.67403182 |
| 21 | protein localization to endosome (GO:0036010) | 3.64330811 |
| 22 | NADH metabolic process (GO:0006734) | 3.62973361 |
| 23 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.61272549 |
| 24 | NIK/NF-kappaB signaling (GO:0038061) | 3.59788486 |
| 25 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.57812573 |
| 26 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.57267731 |
| 27 | glycolipid catabolic process (GO:0019377) | 3.55406559 |
| 28 | folic acid metabolic process (GO:0046655) | 3.54367987 |
| 29 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.53756876 |
| 30 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.52743465 |
| 31 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.51153030 |
| 32 | pinocytosis (GO:0006907) | 3.49953569 |
| 33 | regulation of vitamin metabolic process (GO:0030656) | 3.48579770 |
| 34 | oxaloacetate metabolic process (GO:0006107) | 3.47084535 |
| 35 | DNA strand elongation (GO:0022616) | 3.38442732 |
| 36 | tricarboxylic acid metabolic process (GO:0072350) | 3.36655147 |
| 37 | glycine metabolic process (GO:0006544) | 3.36434104 |
| 38 | cardiac myofibril assembly (GO:0055003) | 3.35597053 |
| 39 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.34881141 |
| 40 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.31144079 |
| 41 | oligosaccharide catabolic process (GO:0009313) | 3.30372164 |
| 42 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.28590027 |
| 43 | neutrophil activation involved in immune response (GO:0002283) | 3.27520469 |
| 44 | maturation of SSU-rRNA (GO:0030490) | 3.26995139 |
| 45 | formation of translation preinitiation complex (GO:0001731) | 3.25937231 |
| 46 | ribosomal small subunit biogenesis (GO:0042274) | 3.25224952 |
| 47 | valine metabolic process (GO:0006573) | 3.23960963 |
| 48 | nucleobase biosynthetic process (GO:0046112) | 3.23436456 |
| 49 | translational initiation (GO:0006413) | 3.22882402 |
| 50 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.20826616 |
| 51 | aspartate family amino acid catabolic process (GO:0009068) | 3.19731038 |
| 52 | DNA replication initiation (GO:0006270) | 3.19283099 |
| 53 | regulation of podosome assembly (GO:0071801) | 3.19126353 |
| 54 | response to thyroid hormone (GO:0097066) | 3.18686869 |
| 55 | protein targeting to ER (GO:0045047) | 3.16723905 |
| 56 | cotranslational protein targeting to membrane (GO:0006613) | 3.14841368 |
| 57 | carnitine shuttle (GO:0006853) | 3.11551658 |
| 58 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.11454944 |
| 59 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.11454944 |
| 60 | modulation by symbiont of host immune response (GO:0052553) | 3.11454944 |
| 61 | positive regulation by symbiont of host defense response (GO:0052509) | 3.11454944 |
| 62 | modulation by symbiont of host defense response (GO:0052031) | 3.11454944 |
| 63 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.11454944 |
| 64 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.10805511 |
| 65 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.09618594 |
| 66 | IMP biosynthetic process (GO:0006188) | 3.06271831 |
| 67 | regulation of early endosome to late endosome transport (GO:2000641) | 3.06076832 |
| 68 | regulation of cofactor metabolic process (GO:0051193) | 3.05597389 |
| 69 | regulation of coenzyme metabolic process (GO:0051196) | 3.05597389 |
| 70 | purine nucleobase biosynthetic process (GO:0009113) | 3.04545300 |
| 71 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.04312802 |
| 72 | DNA unwinding involved in DNA replication (GO:0006268) | 3.04176844 |
| 73 | fatty acid beta-oxidation (GO:0006635) | 3.04112101 |
| 74 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.03573536 |
| 75 | glyoxylate metabolic process (GO:0046487) | 3.02267648 |
| 76 | protein localization to endoplasmic reticulum (GO:0070972) | 3.00959777 |
| 77 | succinate metabolic process (GO:0006105) | 2.99630491 |
| 78 | macrophage activation involved in immune response (GO:0002281) | 2.99281438 |
| 79 | respiratory electron transport chain (GO:0022904) | 2.98942838 |
| 80 | IMP metabolic process (GO:0046040) | 2.97649610 |
| 81 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.96269680 |
| 82 | ribosomal large subunit biogenesis (GO:0042273) | 2.95499080 |
| 83 | ubiquinone biosynthetic process (GO:0006744) | 2.95417380 |
| 84 | quinone biosynthetic process (GO:1901663) | 2.95417380 |
| 85 | regulation of superoxide anion generation (GO:0032928) | 2.94837124 |
| 86 | ceramide catabolic process (GO:0046514) | 2.92495192 |
| 87 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.91660985 |
| 88 | viral life cycle (GO:0019058) | 2.90774537 |
| 89 | aerobic respiration (GO:0009060) | 2.90755817 |
| 90 | electron transport chain (GO:0022900) | 2.90467078 |
| 91 | cellular protein complex disassembly (GO:0043624) | 2.87982803 |
| 92 | regulation of mononuclear cell migration (GO:0071675) | 2.87964290 |
| 93 | cardiac muscle cell development (GO:0055013) | 2.87130791 |
| 94 | telomere maintenance via recombination (GO:0000722) | 2.86592700 |
| 95 | regulation of cholesterol storage (GO:0010885) | 2.86095061 |
| 96 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.85659506 |
| 97 | fatty acid transmembrane transport (GO:1902001) | 2.84784708 |
| 98 | pseudouridine synthesis (GO:0001522) | 2.83214021 |
| 99 | germinal center formation (GO:0002467) | 2.83119104 |
| 100 | serine family amino acid biosynthetic process (GO:0009070) | 2.82418349 |
| 101 | AMP metabolic process (GO:0046033) | 2.81625448 |
| 102 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.81208990 |
| 103 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.80690670 |
| 104 | mitochondrial RNA metabolic process (GO:0000959) | 2.80388407 |
| 105 | detection of molecule of bacterial origin (GO:0032490) | 2.80112369 |
| 106 | myofibril assembly (GO:0030239) | 2.79821514 |
| 107 | branched-chain amino acid catabolic process (GO:0009083) | 2.78454187 |
| 108 | carnitine metabolic process (GO:0009437) | 2.77450673 |
| 109 | cardiac muscle contraction (GO:0060048) | 2.75748241 |
| 110 | myeloid dendritic cell differentiation (GO:0043011) | 2.75621956 |
| 111 | heart contraction (GO:0060047) | 2.75203992 |
| 112 | heart process (GO:0003015) | 2.75203992 |
| 113 | galactose catabolic process (GO:0019388) | 2.75121779 |
| 114 | regulation of chemokine biosynthetic process (GO:0045073) | 2.74184420 |
| 115 | translation (GO:0006412) | 2.68239405 |
| 116 | membrane lipid catabolic process (GO:0046466) | 2.67701264 |
| 117 | response to muramyl dipeptide (GO:0032495) | 2.67450032 |
| 118 | modulation by symbiont of host cellular process (GO:0044068) | 2.67391122 |
| 119 | branched-chain amino acid metabolic process (GO:0009081) | 2.67099388 |
| 120 | amino-acid betaine metabolic process (GO:0006577) | 2.66812095 |
| 121 | transcription from mitochondrial promoter (GO:0006390) | 2.66337205 |
| 122 | ribosome biogenesis (GO:0042254) | 2.66006260 |
| 123 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.65816028 |
| 124 | fatty acid catabolic process (GO:0009062) | 2.65205802 |
| 125 | serine family amino acid metabolic process (GO:0009069) | 2.64702875 |
| 126 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.64644993 |
| 127 | activation of MAPKKK activity (GO:0000185) | 2.63160933 |
| 128 | T-helper 1 type immune response (GO:0042088) | 2.62888132 |
| 129 | cardiac cell development (GO:0055006) | 2.62593555 |
| 130 | Golgi transport vesicle coating (GO:0048200) | 2.62184452 |
| 131 | COPI coating of Golgi vesicle (GO:0048205) | 2.62184452 |
| 132 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.61377144 |
| 133 | regulation of mitochondrial translation (GO:0070129) | 2.61366922 |
| 134 | telomere maintenance via telomere lengthening (GO:0010833) | 2.61299587 |
| 135 | ethanol oxidation (GO:0006069) | 2.61216293 |
| 136 | pentose-phosphate shunt (GO:0006098) | 2.60682441 |
| 137 | fatty acid oxidation (GO:0019395) | 2.60161100 |
| 138 | regulation of sulfur metabolic process (GO:0042762) | 2.60104806 |
| 139 | heme biosynthetic process (GO:0006783) | 2.59011561 |
| 140 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.58708314 |
| 141 | sphingolipid catabolic process (GO:0030149) | 2.57425876 |
| 142 | muscle filament sliding (GO:0030049) | 2.55872147 |
| 143 | actin-myosin filament sliding (GO:0033275) | 2.55872147 |
| 144 | aspartate family amino acid metabolic process (GO:0009066) | 2.55607346 |
| 145 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 2.54719885 |
| 146 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 2.54719885 |
| 147 | regulation of integrin activation (GO:0033623) | 2.54325097 |
| 148 | protein complex disassembly (GO:0043241) | 2.54070180 |
| 149 | cellular response to lipopolysaccharide (GO:0071222) | 2.53608448 |
| 150 | regulation of mast cell degranulation (GO:0043304) | 2.52852859 |
| 151 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.52342581 |
| 152 | mitotic chromosome condensation (GO:0007076) | 2.51698136 |
| 153 | lipid oxidation (GO:0034440) | 2.51257290 |
| 154 | mitotic recombination (GO:0006312) | 2.50839394 |
| 155 | cellular protein complex localization (GO:0034629) | 2.50014658 |
| 156 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.49684620 |
| 157 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.49609207 |
| 158 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.48478559 |
| 159 | immunoglobulin mediated immune response (GO:0016064) | 2.45493453 |
| 160 | granulocyte activation (GO:0036230) | 2.44706031 |
| 161 | cellular extravasation (GO:0045123) | 2.43735885 |
| 162 | regulation of leukocyte degranulation (GO:0043300) | 2.42769419 |
| 163 | cellular response to molecule of bacterial origin (GO:0071219) | 2.42702427 |
| 164 | decidualization (GO:0046697) | 2.41348346 |
| 165 | response to progesterone (GO:0032570) | 2.39359362 |
| 166 | regulation of translational termination (GO:0006449) | 2.36822964 |
| 167 | monocyte chemotaxis (GO:0002548) | 2.34973574 |
| 168 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.34390231 |
| 169 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.34115629 |
| 170 | positive regulation of extracellular matrix organization (GO:1903055) | 2.33830434 |
| 171 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.33632630 |
| 172 | pyrimidine-containing compound salvage (GO:0008655) | 2.33617860 |
| 173 | pyrimidine nucleoside salvage (GO:0043097) | 2.33617860 |
| 174 | myeloid dendritic cell activation (GO:0001773) | 2.33476187 |
| 175 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.32900314 |
| 176 | positive regulation of interleukin-6 production (GO:0032755) | 2.32585266 |
| 177 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.30457757 |
| 178 | response to laminar fluid shear stress (GO:0034616) | 2.30215967 |
| 179 | adenosine receptor signaling pathway (GO:0001973) | 2.29575635 |
| 180 | * cellular response to arsenic-containing substance (GO:0071243) | 2.29048900 |
| 181 | detection of other organism (GO:0098543) | 2.26822620 |
| 182 | detection of external biotic stimulus (GO:0098581) | 2.26667578 |
| 183 | proline biosynthetic process (GO:0006561) | 2.26379432 |
| 184 | amino sugar catabolic process (GO:0046348) | 2.26132968 |
| 185 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.25820702 |
| 186 | stress fiber assembly (GO:0043149) | 2.25717536 |
| 187 | regulation of fever generation (GO:0031620) | 2.25450645 |
| 188 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.23955493 |
| 189 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.23396734 |
| 190 | NADPH regeneration (GO:0006740) | 2.23386806 |
| 191 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.23087500 |
| 192 | TRIF-dependent toll-like receptor signaling pathway (GO:0035666) | 2.19998314 |
| 193 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.19509044 |
| 194 | toll-like receptor 3 signaling pathway (GO:0034138) | 2.19450566 |
| 195 | regulation of macrophage chemotaxis (GO:0010758) | 2.19292963 |
| 196 | cellular response to biotic stimulus (GO:0071216) | 2.17831134 |
| 197 | hyaluronan catabolic process (GO:0030214) | 2.16948248 |
| 198 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.16063404 |
| 199 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.15623569 |
| 200 | glucose 6-phosphate metabolic process (GO:0051156) | 2.15224375 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.35199865 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.33054473 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.75463042 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.60615524 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.34016383 |
| 6 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.58094232 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.49593283 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.49547402 |
| 9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.47651345 |
| 10 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.40661084 |
| 11 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.33284281 |
| 12 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.29254564 |
| 13 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.27681247 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.18426811 |
| 15 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.17522167 |
| 16 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.12670681 |
| 17 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.04586145 |
| 18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.03598735 |
| 19 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99564351 |
| 20 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.97052340 |
| 21 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.95414587 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.95413882 |
| 23 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.91079955 |
| 24 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.90045503 |
| 25 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.89098726 |
| 26 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.88861681 |
| 27 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.84740211 |
| 28 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.83408545 |
| 29 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.82951540 |
| 30 | * MYC_22102868_ChIP-Seq_BL_Human | 1.82862198 |
| 31 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.80683441 |
| 32 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.78883898 |
| 33 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.78720474 |
| 34 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.77538306 |
| 35 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.77438369 |
| 36 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.76500764 |
| 37 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.68273805 |
| 38 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.67971587 |
| 39 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.67781387 |
| 40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.67005956 |
| 41 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.65687808 |
| 42 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.63325611 |
| 43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.63012207 |
| 44 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.62295041 |
| 45 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.61975970 |
| 46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.60983184 |
| 47 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.60214004 |
| 48 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.60064189 |
| 49 | * TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.59755863 |
| 50 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57685048 |
| 51 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.57370059 |
| 52 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.55433443 |
| 53 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.54623345 |
| 54 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.54231905 |
| 55 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.54173065 |
| 56 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.53337766 |
| 57 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.53192283 |
| 58 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.53064433 |
| 59 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.48369511 |
| 60 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.48147753 |
| 61 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.47390863 |
| 62 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.46656478 |
| 63 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.45031331 |
| 64 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.43780263 |
| 65 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43600352 |
| 66 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.43151595 |
| 67 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.42754705 |
| 68 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.42331728 |
| 69 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41723383 |
| 70 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.40040048 |
| 71 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.39570491 |
| 72 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.37364332 |
| 73 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.35376061 |
| 74 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34643693 |
| 75 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.33533863 |
| 76 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.33498599 |
| 77 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.33185121 |
| 78 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.32580835 |
| 79 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30830528 |
| 80 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.30829304 |
| 81 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.30522195 |
| 82 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.28871474 |
| 83 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.28456241 |
| 84 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.28371624 |
| 85 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.28345282 |
| 86 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.27846013 |
| 87 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.26742312 |
| 88 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.24691111 |
| 89 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.24209368 |
| 90 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.23653634 |
| 91 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23074106 |
| 92 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.23015114 |
| 93 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.22826105 |
| 94 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.22638236 |
| 95 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21829063 |
| 96 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.21827909 |
| 97 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.21614483 |
| 98 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21317071 |
| 99 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18670617 |
| 100 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.16995379 |
| 101 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15714396 |
| 102 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.15458722 |
| 103 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.14718798 |
| 104 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.14550200 |
| 105 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.14049913 |
| 106 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.13890313 |
| 107 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.13715682 |
| 108 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.13308208 |
| 109 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.12855017 |
| 110 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.11703590 |
| 111 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.11674982 |
| 112 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11554191 |
| 113 | * MAF_26560356_Chip-Seq_TH2_Human | 1.11286183 |
| 114 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.09831050 |
| 115 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09283635 |
| 116 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.08520321 |
| 117 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.07977204 |
| 118 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07842285 |
| 119 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.06809979 |
| 120 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.06539234 |
| 121 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.05612905 |
| 122 | SPI1_23127762_ChIP-Seq_K562_Human | 1.03683186 |
| 123 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03359862 |
| 124 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.02898605 |
| 125 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.02033754 |
| 126 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.01864503 |
| 127 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.01750063 |
| 128 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.01423873 |
| 129 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01011937 |
| 130 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.99967099 |
| 131 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.99875533 |
| 132 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.97571707 |
| 133 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.96837239 |
| 134 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.96704040 |
| 135 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.96314104 |
| 136 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.95889375 |
| 137 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.95062888 |
| 138 | MAF_26560356_Chip-Seq_TH1_Human | 0.94717332 |
| 139 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.94621671 |
| 140 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.94444412 |
| 141 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.93898809 |
| 142 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.91695454 |
| 143 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.89575639 |
| 144 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.89346871 |
| 145 | ATF3_27146783_Chip-Seq_COLON_Human | 0.88227926 |
| 146 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.87555709 |
| 147 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.87093972 |
| 148 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86995744 |
| 149 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.86988785 |
| 150 | UTX_26944678_Chip-Seq_JUKART_Human | 0.86168188 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 4.22979638 |
| 2 | MP0003303_peritoneal_inflammation | 3.76967465 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 3.70913100 |
| 4 | MP0005058_abnormal_lysosome_morphology | 3.68802576 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.65377769 |
| 6 | MP0004084_abnormal_cardiac_muscle | 3.65061166 |
| 7 | MP0005451_abnormal_body_composition | 3.34092235 |
| 8 | MP0004215_abnormal_myocardial_fiber | 3.09088661 |
| 9 | MP0003436_decreased_susceptibility_to | 2.86368050 |
| 10 | MP0005330_cardiomyopathy | 2.74292651 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 2.72662656 |
| 12 | MP0004510_myositis | 2.63722185 |
| 13 | MP0005360_urolithiasis | 2.63204702 |
| 14 | MP0005085_abnormal_gallbladder_physiolo | 2.47230494 |
| 15 | MP0000751_myopathy | 2.46937798 |
| 16 | * MP0006036_abnormal_mitochondrial_physio | 2.41242786 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.36565444 |
| 18 | MP0002396_abnormal_hematopoietic_system | 2.33733136 |
| 19 | MP0003693_abnormal_embryo_hatching | 2.28230508 |
| 20 | MP0004036_abnormal_muscle_relaxation | 2.27054269 |
| 21 | MP0002877_abnormal_melanocyte_morpholog | 2.25721082 |
| 22 | MP0005365_abnormal_bile_salt | 2.25354799 |
| 23 | MP0003453_abnormal_keratinocyte_physiol | 2.21319653 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.09970601 |
| 25 | MP0004947_skin_inflammation | 2.05343963 |
| 26 | MP0000749_muscle_degeneration | 2.03177551 |
| 27 | MP0009278_abnormal_bone_marrow | 2.00252293 |
| 28 | MP0009840_abnormal_foam_cell | 2.00048888 |
| 29 | MP0002419_abnormal_innate_immunity | 1.93936371 |
| 30 | MP0003221_abnormal_cardiomyocyte_apopto | 1.91873860 |
| 31 | MP0009785_altered_susceptibility_to | 1.91249067 |
| 32 | MP0008775_abnormal_heart_ventricle | 1.89302352 |
| 33 | MP0004957_abnormal_blastocyst_morpholog | 1.82839028 |
| 34 | MP0010630_abnormal_cardiac_muscle | 1.81900673 |
| 35 | MP0005000_abnormal_immune_tolerance | 1.81435411 |
| 36 | MP0000858_altered_metastatic_potential | 1.80485873 |
| 37 | MP0006082_CNS_inflammation | 1.79539502 |
| 38 | MP0005385_cardiovascular_system_phenoty | 1.76333638 |
| 39 | MP0001544_abnormal_cardiovascular_syste | 1.76333638 |
| 40 | MP0005464_abnormal_platelet_physiology | 1.76023939 |
| 41 | MP0003656_abnormal_erythrocyte_physiolo | 1.75623444 |
| 42 | MP0008260_abnormal_autophagy | 1.74412003 |
| 43 | MP0004087_abnormal_muscle_fiber | 1.71092489 |
| 44 | MP0010094_abnormal_chromosome_stability | 1.69572626 |
| 45 | MP0002269_muscular_atrophy | 1.67898081 |
| 46 | MP0005025_abnormal_response_to | 1.66361808 |
| 47 | MP0006035_abnormal_mitochondrial_morpho | 1.65390536 |
| 48 | MP0004147_increased_porphyrin_level | 1.64888623 |
| 49 | MP0003567_abnormal_fetal_cardiomyocyte | 1.63532166 |
| 50 | MP0003172_abnormal_lysosome_physiology | 1.63523273 |
| 51 | MP0001835_abnormal_antigen_presentation | 1.62662340 |
| 52 | MP0008875_abnormal_xenobiotic_pharmacok | 1.62034809 |
| 53 | MP0000750_abnormal_muscle_regeneration | 1.61860569 |
| 54 | * MP0003075_altered_response_to | 1.61407059 |
| 55 | MP0003186_abnormal_redox_activity | 1.61311774 |
| 56 | MP0005076_abnormal_cell_differentiation | 1.61039249 |
| 57 | MP0002972_abnormal_cardiac_muscle | 1.59663218 |
| 58 | MP0004130_abnormal_muscle_cell | 1.57711952 |
| 59 | MP0005319_abnormal_enzyme/_coenzyme | 1.55961410 |
| 60 | MP0003111_abnormal_nucleus_morphology | 1.55645840 |
| 61 | MP0010234_abnormal_vibrissa_follicle | 1.53815034 |
| 62 | MP0003137_abnormal_impulse_conducting | 1.50108532 |
| 63 | MP0009764_decreased_sensitivity_to | 1.48312756 |
| 64 | MP0000604_amyloidosis | 1.47575292 |
| 65 | MP0003077_abnormal_cell_cycle | 1.45446683 |
| 66 | MP0004185_abnormal_adipocyte_glucose | 1.45150334 |
| 67 | MP0004233_abnormal_muscle_weight | 1.45036205 |
| 68 | MP0003448_altered_tumor_morphology | 1.44099553 |
| 69 | MP0002452_abnormal_antigen_presenting | 1.43280473 |
| 70 | MP0001533_abnormal_skeleton_physiology | 1.42496571 |
| 71 | MP0002796_impaired_skin_barrier | 1.40775311 |
| 72 | MP0002998_abnormal_bone_remodeling | 1.40603809 |
| 73 | MP0003724_increased_susceptibility_to | 1.39817738 |
| 74 | MP0003828_pulmonary_edema | 1.38395601 |
| 75 | MP0006138_congestive_heart_failure | 1.38220263 |
| 76 | MP0002723_abnormal_immune_serum | 1.36696003 |
| 77 | MP0001790_abnormal_immune_system | 1.36118261 |
| 78 | MP0005387_immune_system_phenotype | 1.36118261 |
| 79 | MP0005266_abnormal_metabolism | 1.34075465 |
| 80 | MP0005332_abnormal_amino_acid | 1.33300443 |
| 81 | MP0005397_hematopoietic_system_phenotyp | 1.33110270 |
| 82 | MP0001545_abnormal_hematopoietic_system | 1.33110270 |
| 83 | MP0002106_abnormal_muscle_physiology | 1.30811761 |
| 84 | MP0003566_abnormal_cell_adhesion | 1.29551238 |
| 85 | MP0010352_gastrointestinal_tract_polyps | 1.29306941 |
| 86 | MP0008004_abnormal_stomach_pH | 1.23995553 |
| 87 | MP0001853_heart_inflammation | 1.23464437 |
| 88 | MP0001845_abnormal_inflammatory_respons | 1.23192858 |
| 89 | MP0004484_altered_response_of | 1.20545565 |
| 90 | MP0005671_abnormal_response_to | 1.18623920 |
| 91 | MP0002420_abnormal_adaptive_immunity | 1.18560272 |
| 92 | MP0001819_abnormal_immune_cell | 1.17995708 |
| 93 | MP0001800_abnormal_humoral_immune | 1.17978164 |
| 94 | MP0005083_abnormal_biliary_tract | 1.17570702 |
| 95 | MP0010329_abnormal_lipoprotein_level | 1.17549157 |
| 96 | MP0010155_abnormal_intestine_physiology | 1.17012123 |
| 97 | MP0000609_abnormal_liver_physiology | 1.15967137 |
| 98 | MP0002405_respiratory_system_inflammati | 1.11773566 |
| 99 | MP0004808_abnormal_hematopoietic_stem | 1.11012076 |
| 100 | MP0005620_abnormal_muscle_contractility | 1.11004755 |
| 101 | MP0000490_abnormal_crypts_of | 1.10618231 |
| 102 | MP0005666_abnormal_adipose_tissue | 1.10524618 |
| 103 | MP0003191_abnormal_cellular_cholesterol | 1.10036104 |
| 104 | MP0001849_ear_inflammation | 1.09826698 |
| 105 | MP0000747_muscle_weakness | 1.09603868 |
| 106 | MP0010307_abnormal_tumor_latency | 1.06880364 |
| 107 | MP0003252_abnormal_bile_duct | 1.06432359 |
| 108 | MP0008057_abnormal_DNA_replication | 1.03993884 |
| 109 | MP0003091_abnormal_cell_migration | 1.03881410 |
| 110 | MP0001216_abnormal_epidermal_layer | 1.03471415 |
| 111 | MP0005670_abnormal_white_adipose | 1.03067646 |
| 112 | MP0010368_abnormal_lymphatic_system | 1.01891482 |
| 113 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.01781146 |
| 114 | MP0008058_abnormal_DNA_repair | 1.00539711 |
| 115 | MP0001666_abnormal_nutrient_absorption | 1.00244264 |
| 116 | MP0005501_abnormal_skin_physiology | 0.99735705 |
| 117 | MP0001764_abnormal_homeostasis | 0.98464517 |
| 118 | MP0008007_abnormal_cellular_replicative | 0.97767529 |
| 119 | MP0005023_abnormal_wound_healing | 0.97682022 |
| 120 | MP0002127_abnormal_cardiovascular_syste | 0.97482074 |
| 121 | MP0002332_abnormal_exercise_endurance | 0.96916490 |
| 122 | MP0006054_spinal_hemorrhage | 0.96628135 |
| 123 | * MP0005166_decreased_susceptibility_to | 0.96561075 |
| 124 | MP0009643_abnormal_urine_homeostasis | 0.96338135 |
| 125 | MP0001727_abnormal_embryo_implantation | 0.94524124 |
| 126 | MP0003705_abnormal_hypodermis_morpholog | 0.92451887 |
| 127 | MP0000598_abnormal_liver_morphology | 0.92198836 |
| 128 | MP0000716_abnormal_immune_system | 0.91374728 |
| 129 | MP0003763_abnormal_thymus_physiology | 0.91151675 |
| 130 | MP0003984_embryonic_growth_retardation | 0.90219313 |
| 131 | MP0002429_abnormal_blood_cell | 0.89967840 |
| 132 | MP0002254_reproductive_system_inflammat | 0.89621207 |
| 133 | MP0005310_abnormal_salivary_gland | 0.88927726 |
| 134 | MP0005369_muscle_phenotype | 0.88511421 |
| 135 | MP0003329_amyloid_beta_deposits | 0.88448846 |
| 136 | MP0002088_abnormal_embryonic_growth/wei | 0.87164350 |
| 137 | MP0000759_abnormal_skeletal_muscle | 0.87127498 |
| 138 | * MP0000343_altered_response_to | 0.86623962 |
| 139 | MP0001730_embryonic_growth_arrest | 0.86181626 |
| 140 | MP0005167_abnormal_blood-brain_barrier | 0.85242617 |
| 141 | MP0009333_abnormal_splenocyte_physiolog | 0.85129020 |
| 142 | MP0002019_abnormal_tumor_incidence | 0.84026225 |
| 143 | MP0009763_increased_sensitivity_to | 0.83837203 |
| 144 | MP0000358_abnormal_cell_content/ | 0.83212767 |
| 145 | MP0000266_abnormal_heart_morphology | 0.81207067 |
| 146 | MP0004858_abnormal_nervous_system | 0.80376735 |
| 147 | MP0002118_abnormal_lipid_homeostasis | 0.78892558 |
| 148 | MP0005375_adipose_tissue_phenotype | 0.78189887 |
| 149 | MP0005165_increased_susceptibility_to | 0.75999997 |
| 150 | MP0002080_prenatal_lethality | 0.75697314 |
| 151 | MP0001672_abnormal_embryogenesis/_devel | 0.75677259 |
| 152 | MP0005380_embryogenesis_phenotype | 0.75677259 |
| 153 | MP0000689_abnormal_spleen_morphology | 0.75565858 |
| 154 | MP0004085_abnormal_heartbeat | 0.75067952 |
| 155 | MP0008469_abnormal_protein_level | 0.74599765 |
| 156 | MP0002722_abnormal_immune_system | 0.74473076 |
| 157 | MP0001873_stomach_inflammation | 0.74247377 |
| 158 | MP0002398_abnormal_bone_marrow | 0.73551974 |
| 159 | MP0002132_abnormal_respiratory_system | 0.72315363 |
| 160 | * MP0000313_abnormal_cell_death | 0.70854106 |
| 161 | MP0003690_abnormal_glial_cell | 0.70016714 |
| 162 | MP0005164_abnormal_response_to | 0.69959123 |
| 163 | MP0000350_abnormal_cell_proliferation | 0.69247908 |
| 164 | MP0000685_abnormal_immune_system | 0.69180311 |
| 165 | MP0005376_homeostasis/metabolism_phenot | 0.68750056 |
| 166 | MP0005636_abnormal_mineral_homeostasis | 0.68724914 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 5.05869858 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.05869858 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.05869858 |
| 4 | Ventricular tachycardia (HP:0004756) | 4.36336324 |
| 5 | Sudden death (HP:0001699) | 4.23267216 |
| 6 | Hepatic necrosis (HP:0002605) | 4.17400902 |
| 7 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.87441931 |
| 8 | Abnormal number of erythroid precursors (HP:0012131) | 3.84519939 |
| 9 | Increased cerebral lipofuscin (HP:0011813) | 3.82549000 |
| 10 | Myoglobinuria (HP:0002913) | 3.74634487 |
| 11 | Abnormality of macrophages (HP:0004311) | 3.70208390 |
| 12 | Hepatocellular necrosis (HP:0001404) | 3.70143582 |
| 13 | Dicarboxylic aciduria (HP:0003215) | 3.69009654 |
| 14 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.69009654 |
| 15 | Rhabdomyolysis (HP:0003201) | 3.68857786 |
| 16 | Palpitations (HP:0001962) | 3.61914560 |
| 17 | Hypoglycemic coma (HP:0001325) | 3.56906774 |
| 18 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.52172487 |
| 19 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.52172487 |
| 20 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.46177997 |
| 21 | Lipoatrophy (HP:0100578) | 3.43080950 |
| 22 | Increased muscle lipid content (HP:0009058) | 3.40241946 |
| 23 | Hyperammonemia (HP:0001987) | 3.37313969 |
| 24 | Ragged-red muscle fibers (HP:0003200) | 3.29546679 |
| 25 | Vacuolated lymphocytes (HP:0001922) | 3.27366418 |
| 26 | Loss of speech (HP:0002371) | 3.26895755 |
| 27 | Dysostosis multiplex (HP:0000943) | 3.24030291 |
| 28 | Increased intramyocellular lipid droplets (HP:0012240) | 3.15263928 |
| 29 | Cerebral edema (HP:0002181) | 3.14164560 |
| 30 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.13176082 |
| 31 | Lactic acidosis (HP:0003128) | 3.12770508 |
| 32 | Exercise-induced muscle cramps (HP:0003710) | 3.09173455 |
| 33 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.08774103 |
| 34 | Subaortic stenosis (HP:0001682) | 3.08774103 |
| 35 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.06640194 |
| 36 | Dilated cardiomyopathy (HP:0001644) | 3.02436782 |
| 37 | Increased CSF lactate (HP:0002490) | 3.00740394 |
| 38 | Ketosis (HP:0001946) | 3.00642970 |
| 39 | Systemic lupus erythematosus (HP:0002725) | 2.99561285 |
| 40 | Myocardial infarction (HP:0001658) | 2.98721906 |
| 41 | Right ventricular cardiomyopathy (HP:0011663) | 2.96834598 |
| 42 | Increased serum lactate (HP:0002151) | 2.93322672 |
| 43 | Atrial fibrillation (HP:0005110) | 2.90058272 |
| 44 | Acute encephalopathy (HP:0006846) | 2.89249687 |
| 45 | Generalized aminoaciduria (HP:0002909) | 2.88301748 |
| 46 | Mitochondrial inheritance (HP:0001427) | 2.87463317 |
| 47 | Vertebral compression fractures (HP:0002953) | 2.86723531 |
| 48 | Axonal loss (HP:0003447) | 2.84688994 |
| 49 | Hyperglycinuria (HP:0003108) | 2.83914662 |
| 50 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.83661216 |
| 51 | Supraventricular tachycardia (HP:0004755) | 2.83349052 |
| 52 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.82251893 |
| 53 | Abnormality of alanine metabolism (HP:0010916) | 2.82251893 |
| 54 | Hyperalaninemia (HP:0003348) | 2.82251893 |
| 55 | Ketoacidosis (HP:0001993) | 2.81725290 |
| 56 | Acute necrotizing encephalopathy (HP:0006965) | 2.81213526 |
| 57 | Progressive muscle weakness (HP:0003323) | 2.79793253 |
| 58 | Eczematoid dermatitis (HP:0000976) | 2.78994344 |
| 59 | Multiple enchondromatosis (HP:0005701) | 2.74757128 |
| 60 | Supraventricular arrhythmia (HP:0005115) | 2.74553438 |
| 61 | Primary atrial arrhythmia (HP:0001692) | 2.72277052 |
| 62 | Recurrent bacterial skin infections (HP:0005406) | 2.68750885 |
| 63 | Calf muscle hypertrophy (HP:0008981) | 2.68442838 |
| 64 | Nausea (HP:0002018) | 2.68259300 |
| 65 | Recurrent abscess formation (HP:0002722) | 2.68223931 |
| 66 | Purpura (HP:0000979) | 2.63608401 |
| 67 | Achilles tendon contracture (HP:0001771) | 2.62202783 |
| 68 | Lipid accumulation in hepatocytes (HP:0006561) | 2.60254926 |
| 69 | Upper motor neuron abnormality (HP:0002127) | 2.56873504 |
| 70 | Atrioventricular block (HP:0001678) | 2.56863580 |
| 71 | Exercise-induced myalgia (HP:0003738) | 2.56178925 |
| 72 | Petechiae (HP:0000967) | 2.53803928 |
| 73 | Nuclear cataract (HP:0100018) | 2.52228396 |
| 74 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.52034438 |
| 75 | Lethargy (HP:0001254) | 2.50931754 |
| 76 | Abnormality of glycine metabolism (HP:0010895) | 2.49200069 |
| 77 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.49200069 |
| 78 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.48539167 |
| 79 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.47635763 |
| 80 | Abnormality of the Achilles tendon (HP:0005109) | 2.46933126 |
| 81 | Neoplasm of head and neck (HP:0012288) | 2.46695061 |
| 82 | Esophageal neoplasm (HP:0100751) | 2.46695061 |
| 83 | Muscle fiber splitting (HP:0003555) | 2.46078161 |
| 84 | Oral leukoplakia (HP:0002745) | 2.45993986 |
| 85 | Neurofibrillary tangles (HP:0002185) | 2.42803872 |
| 86 | Exercise intolerance (HP:0003546) | 2.42192354 |
| 87 | Mediastinal lymphadenopathy (HP:0100721) | 2.40395540 |
| 88 | Cerebral inclusion bodies (HP:0100314) | 2.40008656 |
| 89 | Conjunctival hamartoma (HP:0100780) | 2.38794131 |
| 90 | Disinhibition (HP:0000734) | 2.38718766 |
| 91 | Intrahepatic cholestasis (HP:0001406) | 2.36555209 |
| 92 | Hepatosplenomegaly (HP:0001433) | 2.36311531 |
| 93 | Neuronal loss in central nervous system (HP:0002529) | 2.35466570 |
| 94 | Respiratory failure (HP:0002878) | 2.30005000 |
| 95 | Aplastic anemia (HP:0001915) | 2.29204284 |
| 96 | Metabolic acidosis (HP:0001942) | 2.27512415 |
| 97 | Reticulocytopenia (HP:0001896) | 2.25876305 |
| 98 | Progressive external ophthalmoplegia (HP:0000590) | 2.25807750 |
| 99 | Cholecystitis (HP:0001082) | 2.24672207 |
| 100 | Abnormal gallbladder physiology (HP:0012438) | 2.24672207 |
| 101 | Deep venous thrombosis (HP:0002625) | 2.24293857 |
| 102 | Asymmetric septal hypertrophy (HP:0001670) | 2.23173269 |
| 103 | Hyperglycinemia (HP:0002154) | 2.23084073 |
| 104 | Autoimmune thrombocytopenia (HP:0001973) | 2.21402529 |
| 105 | Syncope (HP:0001279) | 2.21358823 |
| 106 | Heart block (HP:0012722) | 2.20741209 |
| 107 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.20130480 |
| 108 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.19520859 |
| 109 | Abnormality of serum amino acid levels (HP:0003112) | 2.17413913 |
| 110 | Distal lower limb amyotrophy (HP:0008944) | 2.17121439 |
| 111 | Increased hepatocellular lipid droplets (HP:0006565) | 2.16410386 |
| 112 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.16373296 |
| 113 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.16373296 |
| 114 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.16373296 |
| 115 | Abnormality of glycolysis (HP:0004366) | 2.15873949 |
| 116 | Increased serum pyruvate (HP:0003542) | 2.15873949 |
| 117 | Amyloidosis (HP:0011034) | 2.15214576 |
| 118 | Hyperbilirubinemia (HP:0002904) | 2.14757592 |
| 119 | Chronic obstructive pulmonary disease (HP:0006510) | 2.14706343 |
| 120 | Obstructive lung disease (HP:0006536) | 2.14706343 |
| 121 | Increased IgE level (HP:0003212) | 2.14669596 |
| 122 | Ventricular arrhythmia (HP:0004308) | 2.13049204 |
| 123 | Progressive macrocephaly (HP:0004481) | 2.10340884 |
| 124 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.10024647 |
| 125 | Apathy (HP:0000741) | 2.09972699 |
| 126 | Bundle branch block (HP:0011710) | 2.09636571 |
| 127 | Increased serum ferritin (HP:0003281) | 2.08575403 |
| 128 | Microvesicular hepatic steatosis (HP:0001414) | 2.07531093 |
| 129 | Thrombocytosis (HP:0001894) | 2.05644479 |
| 130 | Mucopolysacchariduria (HP:0008155) | 2.05415884 |
| 131 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.05415884 |
| 132 | Hypobetalipoproteinemia (HP:0003563) | 2.05346140 |
| 133 | Macrocytic anemia (HP:0001972) | 2.04763620 |
| 134 | Diminished motivation (HP:0000745) | 2.04744768 |
| 135 | Tetraparesis (HP:0002273) | 2.04557566 |
| 136 | Bone pain (HP:0002653) | 2.03769156 |
| 137 | Orchitis (HP:0100796) | 2.03653761 |
| 138 | Abnormal atrioventricular conduction (HP:0005150) | 2.02930502 |
| 139 | CNS demyelination (HP:0007305) | 2.02554586 |
| 140 | Abnormality of the calf musculature (HP:0001430) | 2.02297840 |
| 141 | Abnormality of iron homeostasis (HP:0011031) | 2.01952378 |
| 142 | Pallor (HP:0000980) | 2.00241575 |
| 143 | Distal lower limb muscle weakness (HP:0009053) | 1.98717537 |
| 144 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.98273899 |
| 145 | Proximal tubulopathy (HP:0000114) | 1.98158557 |
| 146 | Hypertensive crisis (HP:0100735) | 1.98039592 |
| 147 | Personality changes (HP:0000751) | 1.97732711 |
| 148 | Fatigue (HP:0012378) | 1.96834460 |
| 149 | Recurrent viral infections (HP:0004429) | 1.96626129 |
| 150 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.96554014 |
| 151 | Rough bone trabeculation (HP:0100670) | 1.96542006 |
| 152 | Abnormality of complement system (HP:0005339) | 1.95241689 |
| 153 | Vomiting (HP:0002013) | 1.92020627 |
| 154 | Late onset (HP:0003584) | 1.91721718 |
| 155 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.91630693 |
| 156 | Delayed CNS myelination (HP:0002188) | 1.91559560 |
| 157 | Xanthomatosis (HP:0000991) | 1.91496088 |
| 158 | Adenoma sebaceum (HP:0009720) | 1.90981475 |
| 159 | Angiofibromas (HP:0010615) | 1.90981475 |
| 160 | Hyporeflexia of lower limbs (HP:0002600) | 1.89379983 |
| 161 | Glomerulonephritis (HP:0000099) | 1.88665224 |
| 162 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.87984891 |
| 163 | Increased connective tissue (HP:0009025) | 1.87228720 |
| 164 | Hyperacusis (HP:0010780) | 1.86600616 |
| 165 | Progressive neurologic deterioration (HP:0002344) | 1.86135351 |
| 166 | Pathologic fracture (HP:0002756) | 1.83660026 |
| 167 | Thoracic kyphosis (HP:0002942) | 1.82777533 |
| 168 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.82241448 |
| 169 | Urticaria (HP:0001025) | 1.80958660 |
| 170 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.78288392 |
| 171 | Abnormal trabecular bone morphology (HP:0100671) | 1.76930369 |
| 172 | Hyperparathyroidism (HP:0000843) | 1.76873249 |
| 173 | Slow saccadic eye movements (HP:0000514) | 1.73778826 |
| 174 | Myositis (HP:0100614) | 1.72299344 |
| 175 | Trismus (HP:0000211) | 1.72125143 |
| 176 | Interstitial pulmonary disease (HP:0006530) | 1.70748901 |
| 177 | Hemorrhage of the eye (HP:0011885) | 1.70565756 |
| 178 | Complement deficiency (HP:0004431) | 1.70196906 |
| 179 | Prolonged neonatal jaundice (HP:0006579) | 1.69848633 |
| 180 | Hypertriglyceridemia (HP:0002155) | 1.69422862 |
| 181 | Retrobulbar optic neuritis (HP:0100654) | 1.69034898 |
| 182 | Optic neuritis (HP:0100653) | 1.69034898 |
| 183 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.69027594 |
| 184 | Mutism (HP:0002300) | 1.66439380 |
| 185 | Abnormal platelet function (HP:0011869) | 1.66114605 |
| 186 | Impaired platelet aggregation (HP:0003540) | 1.66114605 |
| 187 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.65826571 |
| 188 | Cellulitis (HP:0100658) | 1.65147207 |
| 189 | Stomatitis (HP:0010280) | 1.64697530 |
| 190 | Thick nail (HP:0001805) | 1.64423140 |
| 191 | Abnormality of the thoracic spine (HP:0100711) | 1.60995384 |
| 192 | Fasciculations (HP:0002380) | 1.60657617 |
| 193 | Paralysis (HP:0003470) | 1.59081400 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 5.91317535 |
| 2 | BCKDK | 4.16632048 |
| 3 | NME2 | 3.26498915 |
| 4 | PKN2 | 3.17464323 |
| 5 | PRPF4B | 3.11456231 |
| 6 | NEK1 | 2.99800081 |
| 7 | FLT3 | 2.76467143 |
| 8 | WEE1 | 2.70106787 |
| 9 | TTN | 2.48745932 |
| 10 | SMG1 | 2.40398412 |
| 11 | MAP3K14 | 2.28392275 |
| 12 | EIF2AK1 | 2.20028565 |
| 13 | BUB1 | 2.11290243 |
| 14 | TRIB3 | 2.00910380 |
| 15 | MYLK | 2.00878137 |
| 16 | ICK | 1.95029469 |
| 17 | STK16 | 1.85581579 |
| 18 | KDR | 1.84519471 |
| 19 | MAPKAPK3 | 1.82315474 |
| 20 | PDK3 | 1.81922545 |
| 21 | PDK4 | 1.81922545 |
| 22 | RIPK4 | 1.78030762 |
| 23 | LMTK2 | 1.77879396 |
| 24 | RPS6KB2 | 1.74818478 |
| 25 | PIM2 | 1.72958412 |
| 26 | EEF2K | 1.72365854 |
| 27 | MAP4K1 | 1.72272208 |
| 28 | CDC7 | 1.70422043 |
| 29 | EIF2AK3 | 1.68395875 |
| 30 | MAP2K3 | 1.68342724 |
| 31 | DDR2 | 1.66704732 |
| 32 | CDK12 | 1.61777997 |
| 33 | IRAK4 | 1.60591252 |
| 34 | MAP3K11 | 1.59318153 |
| 35 | STK24 | 1.43339952 |
| 36 | BRSK2 | 1.42199498 |
| 37 | SCYL2 | 1.41440157 |
| 38 | SIK1 | 1.40601324 |
| 39 | ARAF | 1.39748999 |
| 40 | KIT | 1.37419088 |
| 41 | MAP3K10 | 1.36564004 |
| 42 | TIE1 | 1.35049214 |
| 43 | OBSCN | 1.34931028 |
| 44 | TGFBR1 | 1.34868980 |
| 45 | MAP3K3 | 1.32139890 |
| 46 | ERN1 | 1.32064726 |
| 47 | MAP3K13 | 1.30445791 |
| 48 | ACVR1B | 1.27192033 |
| 49 | PINK1 | 1.26711260 |
| 50 | RPS6KA4 | 1.25626410 |
| 51 | NEK2 | 1.24569499 |
| 52 | MAP3K1 | 1.23394689 |
| 53 | IRAK2 | 1.22555326 |
| 54 | CDK4 | 1.20260274 |
| 55 | MUSK | 1.18875944 |
| 56 | MOS | 1.16592674 |
| 57 | LATS2 | 1.16286745 |
| 58 | EPHA2 | 1.14802412 |
| 59 | KSR2 | 1.12986314 |
| 60 | FGR | 1.12090529 |
| 61 | DYRK3 | 1.11932279 |
| 62 | BLK | 1.09496108 |
| 63 | RIPK1 | 1.05239430 |
| 64 | STK4 | 1.04994084 |
| 65 | IKBKB | 1.04500741 |
| 66 | TESK1 | 1.03048894 |
| 67 | LRRK2 | 1.02721629 |
| 68 | ILK | 1.00694815 |
| 69 | PHKG1 | 0.98200931 |
| 70 | PHKG2 | 0.98200931 |
| 71 | MAP3K5 | 0.95437567 |
| 72 | CDK7 | 0.90086353 |
| 73 | CSK | 0.88849921 |
| 74 | MAPK11 | 0.88108453 |
| 75 | CDC42BPA | 0.86299115 |
| 76 | GRK7 | 0.85585430 |
| 77 | BTK | 0.85516364 |
| 78 | VRK1 | 0.84365725 |
| 79 | AURKB | 0.83899243 |
| 80 | PDK2 | 0.80814816 |
| 81 | MAP3K7 | 0.78484756 |
| 82 | TEC | 0.78184394 |
| 83 | CDK6 | 0.77793364 |
| 84 | PDGFRA | 0.77529138 |
| 85 | TYK2 | 0.77478242 |
| 86 | CAMK1D | 0.76913333 |
| 87 | ZAP70 | 0.75608162 |
| 88 | MAP3K8 | 0.75395441 |
| 89 | TBK1 | 0.74082393 |
| 90 | NME1 | 0.73247435 |
| 91 | TAOK2 | 0.72431875 |
| 92 | PIM1 | 0.70997323 |
| 93 | TTK | 0.70362687 |
| 94 | BRAF | 0.66591757 |
| 95 | PAK4 | 0.64740594 |
| 96 | PDPK1 | 0.64566845 |
| 97 | SIK3 | 0.64556730 |
| 98 | ATR | 0.64470099 |
| 99 | BMPR2 | 0.64331766 |
| 100 | PBK | 0.62271387 |
| 101 | MST1R | 0.62247834 |
| 102 | PLK1 | 0.61290386 |
| 103 | BRSK1 | 0.60403290 |
| 104 | DMPK | 0.60079734 |
| 105 | EPHB1 | 0.59613390 |
| 106 | IRAK1 | 0.58235982 |
| 107 | CSF1R | 0.56458941 |
| 108 | PRKG2 | 0.55658519 |
| 109 | TNIK | 0.55162450 |
| 110 | TSSK6 | 0.54968025 |
| 111 | TAOK1 | 0.54095601 |
| 112 | PASK | 0.53505323 |
| 113 | IKBKE | 0.53423793 |
| 114 | MATK | 0.53275694 |
| 115 | JAK3 | 0.52638691 |
| 116 | MAP2K6 | 0.52555226 |
| 117 | BMX | 0.52320751 |
| 118 | MTOR | 0.51938669 |
| 119 | TGFBR2 | 0.51415958 |
| 120 | CHUK | 0.50822628 |
| 121 | PIK3CA | 0.50581502 |
| 122 | STK10 | 0.50404837 |
| 123 | CDK19 | 0.49740272 |
| 124 | TESK2 | 0.48269586 |
| 125 | ALK | 0.47216977 |
| 126 | AKT2 | 0.46691816 |
| 127 | RPS6KA6 | 0.46665889 |
| 128 | RPS6KL1 | 0.45300865 |
| 129 | RPS6KC1 | 0.45300865 |
| 130 | MAPK4 | 0.45016286 |
| 131 | MAP3K9 | 0.43549277 |
| 132 | SRPK1 | 0.42905513 |
| 133 | CLK1 | 0.42850727 |
| 134 | AURKA | 0.42568760 |
| 135 | MAPK12 | 0.42539871 |
| 136 | DAPK3 | 0.41978208 |
| 137 | ABL2 | 0.41955459 |
| 138 | NLK | 0.41543128 |
| 139 | CAMK1 | 0.41126483 |
| 140 | NEK9 | 0.40674271 |
| 141 | PRKAA2 | 0.40157741 |
| 142 | CSNK2A2 | 0.39740937 |
| 143 | PAK1 | 0.39322006 |
| 144 | FGFR4 | 0.39227883 |
| 145 | RAF1 | 0.38872585 |
| 146 | ZAK | 0.36649953 |
| 147 | TYRO3 | 0.33570928 |
| 148 | JAK2 | 0.32009946 |
| 149 | MARK3 | 0.30219405 |
| 150 | RPS6KA1 | 0.30138753 |
| 151 | PDK1 | 0.29709873 |
| 152 | PTK6 | 0.29371692 |
| 153 | CDK9 | 0.29251711 |
| 154 | CHEK2 | 0.28128038 |
| 155 | MAPKAPK2 | 0.27181989 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.06594998 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.53025084 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.36410778 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 3.18042133 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 2.91708555 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.75142921 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.53254217 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51639356 |
| 9 | Carbon metabolism_Homo sapiens_hsa01200 | 2.40078582 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.35652924 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.31436992 |
| 12 | Mismatch repair_Homo sapiens_hsa03430 | 2.23034174 |
| 13 | Bladder cancer_Homo sapiens_hsa05219 | 2.21329588 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.18318379 |
| 15 | Lysosome_Homo sapiens_hsa04142 | 2.17483168 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.15661916 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.99663268 |
| 18 | Leishmaniasis_Homo sapiens_hsa05140 | 1.96906289 |
| 19 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.95669023 |
| 20 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.94534949 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.88846874 |
| 22 | Parkinsons disease_Homo sapiens_hsa05012 | 1.87081556 |
| 23 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.86637818 |
| 24 | Prion diseases_Homo sapiens_hsa05020 | 1.84588537 |
| 25 | Salmonella infection_Homo sapiens_hsa05132 | 1.75369864 |
| 26 | Proteasome_Homo sapiens_hsa03050 | 1.71572358 |
| 27 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.70714199 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.67081302 |
| 29 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.66230383 |
| 30 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.65374875 |
| 31 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.64329279 |
| 32 | Base excision repair_Homo sapiens_hsa03410 | 1.63981150 |
| 33 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.63271462 |
| 34 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.61766791 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.59752671 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.59682984 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.58941008 |
| 38 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.57516642 |
| 39 | Pertussis_Homo sapiens_hsa05133 | 1.55088435 |
| 40 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.54551960 |
| 41 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.53837827 |
| 42 | Sulfur relay system_Homo sapiens_hsa04122 | 1.52984974 |
| 43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.49923635 |
| 44 | Shigellosis_Homo sapiens_hsa05131 | 1.49364147 |
| 45 | Malaria_Homo sapiens_hsa05144 | 1.47330713 |
| 46 | Influenza A_Homo sapiens_hsa05164 | 1.46058582 |
| 47 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.42609057 |
| 48 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.40385248 |
| 49 | RNA polymerase_Homo sapiens_hsa03020 | 1.40298497 |
| 50 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.39492253 |
| 51 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.38923901 |
| 52 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.36107755 |
| 53 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.35780972 |
| 54 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.35257090 |
| 55 | Homologous recombination_Homo sapiens_hsa03440 | 1.34431518 |
| 56 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.33694039 |
| 57 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.33681620 |
| 58 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.33193473 |
| 59 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.32426146 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.31990937 |
| 61 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.30502153 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.28840002 |
| 63 | Apoptosis_Homo sapiens_hsa04210 | 1.26865833 |
| 64 | Spliceosome_Homo sapiens_hsa03040 | 1.24915269 |
| 65 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.24297065 |
| 66 | Peroxisome_Homo sapiens_hsa04146 | 1.23044675 |
| 67 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.22581614 |
| 68 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.18195544 |
| 69 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.18098758 |
| 70 | Hepatitis B_Homo sapiens_hsa05161 | 1.17813505 |
| 71 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.17637579 |
| 72 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.16774358 |
| 73 | Huntingtons disease_Homo sapiens_hsa05016 | 1.15110031 |
| 74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.14775901 |
| 75 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.10896873 |
| 76 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.08904132 |
| 77 | RNA transport_Homo sapiens_hsa03013 | 1.06634297 |
| 78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.04520552 |
| 79 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.03725854 |
| 80 | Hepatitis C_Homo sapiens_hsa05160 | 1.00711138 |
| 81 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.00396077 |
| 82 | Alzheimers disease_Homo sapiens_hsa05010 | 1.00241697 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.99871623 |
| 84 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.97412549 |
| 85 | Phagosome_Homo sapiens_hsa04145 | 0.96697199 |
| 86 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.94289744 |
| 87 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.92131904 |
| 88 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.89949058 |
| 89 | Measles_Homo sapiens_hsa05162 | 0.88897613 |
| 90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.88028770 |
| 91 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.87215905 |
| 92 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.86912745 |
| 93 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.86538252 |
| 94 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.86164865 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.84488169 |
| 96 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.84327110 |
| 97 | Amoebiasis_Homo sapiens_hsa05146 | 0.83208440 |
| 98 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.82652523 |
| 99 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.82548638 |
| 100 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.81877372 |
| 101 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.81247891 |
| 102 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.79012776 |
| 103 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.77580503 |
| 104 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.76310342 |
| 105 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.75836664 |
| 106 | Allograft rejection_Homo sapiens_hsa05330 | 0.74163497 |
| 107 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73621593 |
| 108 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.73403358 |
| 109 | Cell cycle_Homo sapiens_hsa04110 | 0.73042740 |
| 110 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.72258324 |
| 111 | RNA degradation_Homo sapiens_hsa03018 | 0.71690442 |
| 112 | Purine metabolism_Homo sapiens_hsa00230 | 0.71009057 |
| 113 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.69806932 |
| 114 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.69484321 |
| 115 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.67889925 |
| 116 | HTLV-I infection_Homo sapiens_hsa05166 | 0.67827628 |
| 117 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.66944980 |
| 118 | Metabolic pathways_Homo sapiens_hsa01100 | 0.66444652 |
| 119 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.65767128 |
| 120 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65460179 |
| 121 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.64434106 |
| 122 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.63519055 |
| 123 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.62966676 |
| 124 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.62419299 |
| 125 | Lysine degradation_Homo sapiens_hsa00310 | 0.61942353 |
| 126 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.61722628 |
| 127 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.61072383 |
| 128 | Asthma_Homo sapiens_hsa05310 | 0.56967267 |
| 129 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.53542852 |
| 130 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51515878 |
| 131 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.51487647 |
| 132 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.51092187 |
| 133 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.50789362 |
| 134 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.49803350 |
| 135 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47849246 |
| 136 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.47699282 |
| 137 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.46840701 |
| 138 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45547129 |
| 139 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.44901449 |
| 140 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.44790207 |
| 141 | Viral myocarditis_Homo sapiens_hsa05416 | 0.43470448 |
| 142 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43230998 |
| 143 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.41952924 |
| 144 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.41285718 |
| 145 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.41178045 |
| 146 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40929940 |
| 147 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.40790706 |
| 148 | Thyroid cancer_Homo sapiens_hsa05216 | 0.40666281 |
| 149 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40098584 |
| 150 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36356704 |
| 151 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.35356646 |
| 152 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.34165859 |
| 153 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.33860720 |
| 154 | Retinol metabolism_Homo sapiens_hsa00830 | 0.33427318 |
| 155 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.33026468 |
| 156 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.32507098 |
| 157 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.31161513 |
| 158 | ABC transporters_Homo sapiens_hsa02010 | 0.30928910 |
| 159 | Insulin resistance_Homo sapiens_hsa04931 | 0.30398218 |
| 160 | Legionellosis_Homo sapiens_hsa05134 | 0.30046380 |
| 161 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.29551056 |
| 162 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.28598425 |
| 163 | Bile secretion_Homo sapiens_hsa04976 | 0.25783352 |
| 164 | Histidine metabolism_Homo sapiens_hsa00340 | 0.24191163 |
| 165 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.20154310 |
| 166 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.20044902 |
| 167 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.19851201 |

